{"id":17742,"date":"2018-05-01T00:00:10","date_gmt":"2018-05-01T07:00:10","guid":{"rendered":"https:\/\/vermont.salk.edu\/?post_type=disclosure&p=17742"},"modified":"2018-05-18T13:17:40","modified_gmt":"2018-05-18T20:17:40","slug":"single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study","status":"publish","type":"disclosure","link":"https:\/\/www.salk.edu\/zh\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/","title":{"rendered":"Single injection treats hemophilia B for life, in proof-of-concept study"},"content":{"rendered":"

LA JOLLA\u2014For most people with hemophilia B, whose bodies can\u2019t properly form blood clots, constant injections to replenish their clotting factors are a way of life. But now, Salk researchers have demonstrated in mice that hemophilia B can be treated for life with one single injection containing disease-free liver cells that can produce their missing clotting factor. The finding, published in the journal Cell Reports<\/em><\/a> on May 1, 2018, could drastically change what it means to be diagnosed with hemophilia B, and could pave the way toward similar treatments for other, related genetic disorders.<\/p>\n

\"Left<\/a>
Left two panels: Hepatocyte-like cells (HLCs) differentiated from the stem cells of patients with hemophilia B show very low levels of clotting factor IX, or FIX, shown in white. Right two panels: After treating these same cell lines with a gene correction tool, FIX increased to healthy levels. <\/p>\n

Click here<\/a> for a high-resolution image. <\/p>\n

Credit: Salk Institute<\/figcaption><\/figure>\n

Hemophilia B is caused by defects in the gene for a protein called clotting factor IX (FIX). Hemophiliacs may make reduced amounts of the protein, or lack a functional version altogether, leading to life-threatening delays in blood clotting. Currently, patients are treated with injections\u2014as often as a few times a week\u2014containing FIX made in animal cells and then purified. But the approach is expensive, time-consuming and can become less effective over time.<\/p>\n

Recently, Salk scientists developed a new approach, treating mice genetically engineered to have hemophilia B with strands of messenger RNA encoding the FIX gene<\/a>. Like the standard treatment, however, this required repeat injections each time levels of the messenger RNA ran low. So the scientists wanted to try a more permanent approach: transplanting healthy liver cells, capable of producing FIX, into patients.<\/p>\n

\u201cThe appeal of a cell-based approach is that you minimize the number of treatments that a patient needs,\u201d says Suvasini Ramaswamy, a former Salk research associate and first author of the new paper. \u201cRather than constant injections, you can do this in one shot.\u201d<\/p>\n

Since donor livers are often in short-supply, the researchers instead turned to stem-cell strategies to produce the healthy liver cells. They collected blood samples from two human patients with severe hemophilia B, who are unable to produce FIX. Then, in the lab, they reprogrammed the cells into induced pluripotent stem cells (iPSCs), which have the capability to turn into many other cell types, including liver. Using CRISPR\/Cas9, a tool that can alter genes, they then repaired the mutations in each patient\u2019s FIX gene. Finally, they coaxed those repaired cells to develop into liver precursor cells called hepatocyte-like cells (HLCs) and transplanted them into mice with hemophilia B.<\/p>\n

Rather than perform surgery on hemophilic mice\u2014a risky undertaking when their blood can\u2019t always clot\u2014the team transplanted the HLCs through the spleen to distribute the cells uniformly in the liver.<\/p>\n

Not only did the new HLCs produce FIX, but they produced enough of the protein to allow the mice to form normal blood clots, and the cells continued to survive\u2014and produce FIX\u2014for at least a year after the transplantation.<\/p>\n

In people with hemophilia, using their own cells to generate healthy HLCs, then transplanting them back into their bodies, could help avoid the immune complications that often accompany cell therapies. But more work is needed to translate the findings to the clinic.<\/p>\n

\u201cA lot of things have to happen before this can go into humans,\u201d says Ramaswamy.<\/p>\n

Already, she adds, the work demonstrates the value in combining stem-cell reprogramming and new gene-modifying approaches to treat genetic diseases.<\/p>\n

The work and the researchers involved were supported by grants from the National Institutes of Health, the National Cancer Institute, the National Institute of Neurological Disorders and Stroke, the Waitt Foundation, Ipsen, the H. N. and Frances C. Berger Foundation, the Glenn Center for Aging Research, the Leona M. and Harry B. Helmsley Charitable Trust, and the California Institute for Regenerative Medicine.<\/p>","protected":false},"featured_media":0,"template":"","faculty":[115],"disease-research":[146],"class_list":["post-17742","disclosure","type-disclosure","status-publish","hentry","faculty-inder-verma","disease-research-aging-and-regenerative-medicine"],"acf":[],"yoast_head":"\nSingle injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salk.edu\/zh\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Single injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA\u2014For most people with hemophilia B, whose bodies can\u2019t properly form blood clots, constant injections to replenish their clotting factors are a way of life. But now, Salk researchers have demonstrated in mice that hemophilia B can be treated for life with one single injection containing disease-free liver cells that can produce their missing clotting factor. The finding, published in the journal Cell Reports on May 1, 2018, could drastically change what it means to be diagnosed with hemophilia B, and could pave the way toward similar treatments for other, related genetic disorders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salk.edu\/zh\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Salk Institute for Biological Studies\" \/>\n<meta property=\"article:modified_time\" content=\"2018-05-18T20:17:40+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.salk.edu\/wp-content\/uploads\/2018\/04\/F9-before-and-after-correction-458x136.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/\",\"name\":\"Single injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/F9-before-and-after-correction-458x136.jpg\",\"datePublished\":\"2018-05-01T07:00:10+00:00\",\"dateModified\":\"2018-05-18T20:17:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/F9-before-and-after-correction-458x136.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/F9-before-and-after-correction-458x136.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salk.edu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Single injection treats hemophilia B for life, in proof-of-concept study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"name\":\"Salk Institute for Biological Studies\",\"description\":\"The Power of Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salk.edu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\",\"name\":\"Salk Institute for Biological Studies\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Salk Institute for Biological Studies\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Single injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salk.edu\/zh\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/","og_locale":"zh_CN","og_type":"article","og_title":"Single injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies","og_description":"LA JOLLA\u2014For most people with hemophilia B, whose bodies can\u2019t properly form blood clots, constant injections to replenish their clotting factors are a way of life. But now, Salk researchers have demonstrated in mice that hemophilia B can be treated for life with one single injection containing disease-free liver cells that can produce their missing clotting factor. The finding, published in the journal Cell Reports on May 1, 2018, could drastically change what it means to be diagnosed with hemophilia B, and could pave the way toward similar treatments for other, related genetic disorders.","og_url":"https:\/\/www.salk.edu\/zh\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/","og_site_name":"Salk Institute for Biological Studies","article_modified_time":"2018-05-18T20:17:40+00:00","og_image":[{"url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2018\/04\/F9-before-and-after-correction-458x136.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/","url":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/","name":"Single injection treats hemophilia B for life, in proof-of-concept study - Salk Institute for Biological Studies","isPartOf":{"@id":"https:\/\/www.salk.edu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/#primaryimage"},"image":{"@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/#primaryimage"},"thumbnailUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2018\/04\/F9-before-and-after-correction-458x136.jpg","datePublished":"2018-05-01T07:00:10+00:00","dateModified":"2018-05-18T20:17:40+00:00","breadcrumb":{"@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/#primaryimage","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2018\/04\/F9-before-and-after-correction-458x136.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2018\/04\/F9-before-and-after-correction-458x136.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.salk.edu\/news-release\/single-injection-treats-hemophilia-b-for-life-in-proof-of-concept-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salk.edu\/"},{"@type":"ListItem","position":2,"name":"Single injection treats hemophilia B for life, in proof-of-concept study"}]},{"@type":"WebSite","@id":"https:\/\/www.salk.edu\/#website","url":"https:\/\/www.salk.edu\/","name":"\u7d22\u5c14\u514b\u751f\u7269\u7814\u7a76\u6240","description":"The Power of Science","publisher":{"@id":"https:\/\/www.salk.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salk.edu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Organization","@id":"https:\/\/www.salk.edu\/#organization","name":"\u7d22\u5c14\u514b\u751f\u7269\u7814\u7a76\u6240","url":"https:\/\/www.salk.edu\/","logo":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","width":696,"height":696,"caption":"Salk Institute for Biological Studies"},"image":{"@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/"}}]}},"ACF":{"gallery":false,"paper_url":"","journal_title":"Cell Reports","paper_author_list":"Suvasini Ramaswamy, Nina Tonnu, Tushar Menon, Benjamin M. Lewis, Kevin T. Green, Derek Wampler, Paul E. Monahan and Inder M. Verma","paper_title":"Autologous and heterologous cell therapy for hemophilia B towards functional restoration of Factor IX","subhead":"The Salk approach, tested in a mouse model, points to cheaper and more effective treatments for humans","home_photo":"","listing_photo":"","legacy_boilerplate":[],"hide_boilerplate":[],"disable_date":false,"listing_excerpt":"","descriptive_blurb":"","has_journal_cover":false},"_links":{"self":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/17742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure"}],"about":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/types\/disclosure"}],"version-history":[{"count":7,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/17742\/revisions"}],"predecessor-version":[{"id":18050,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/17742\/revisions\/18050"}],"wp:attachment":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/media?parent=17742"}],"wp:term":[{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/faculty?post=17742"},{"taxonomy":"disease-research","embeddable":true,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disease-research?post=17742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}